Skip to content
Review Open access

Impact of balloon guide catheter versus conventional guide catheter on technical and clinical outcomes in mechanical thrombectomy for acute ischemic stroke: a systematic review and meta-analysis

Aug 2026 · Egyptian Journal of Neurosurgery · Vol 41 · 0 citations · 27 references

TL;DR

Findings do not support a recommendation for or against routine BGC use pending confirmatory randomised evidence, and BGC use during EVT is associated with higher excellent functional recovery and first-pass recanalization.

Abstract

Endovascular thrombectomy (EVT) is standard treatment for large vessel occlusion stroke, but the role of balloon guide catheters (BGCs) remains debated. This meta-analysis evaluates BGC versus standard catheters, pooling observational data with the only available randomised trial (PROTECT-MT). Following PRISMA guidelines, observational studies and PROTECT-MT were retrieved from PubMed, Embase, and Cochrane until June 2026. Primary outcomes were excellent (mRS 0–1) and favourable (mRS 0–2) functional recovery at 90 days, 24-hour NIHSS, and procedure time. Secondary outcomes included symptomatic intracranial haemorrhage (sICH), first-pass recanalization (FPR), and 90-day mortality. Random-effects models were used. Post-hoc exploratory subgroup analyses by geographic region and study design investigated heterogeneity. Evidence certainty was assessed using GRADE. Five observational studies and one RCT (2,961 patients; 1,661 BGC, 1,300 non-BGC) were included. BGC use was associated with significantly higher excellent functional outcomes (RR 1.30, 95% CI 1.10–1.53; low certainty) but no difference in favourable outcomes (RR 1.02, 95% CI 0.84–1.24; very low certainty), and significantly higher odds of FPR (OR 2.48, 95% CI 1.76–3.48; moderate certainty). Neither sICH (RR 0.65, 95% CI 0.41–1.02) nor mortality (RR 0.76, 95% CI 0.53–1.08) reached significance overall (both very low certainty). By study design, observational studies alone showed a significant reduction in mortality (RR 0.66, 95% CI 0.46–0.94) and sICH (RR 0.54, 95% CI 0.39–0.74) with BGC, whereas PROTECT-MT alone showed a non-significant trend toward higher rates of both (mortality RR 1.51; sICH RR 1.34); this subgroup difference was significant for mortality (P = 0.005) and sICH (P = 0.006). Study design was also a significant effect modifier for favourable outcome (P for interaction = 0.001): retrospective studies showed benefit (RR 1.35) while prospective studies did not (RR 0.90). Region was not a significant modifier. BGC use during EVT is associated with higher excellent functional recovery and first-pass recanalization. The mortality and sICH benefits suggested by observational data were not replicated in the only available randomised trial, with significant discordance between the two evidence streams. Given predominantly very-low-certainty evidence and this discordance, findings do not support a recommendation for or against routine BGC use pending confirmatory randomised evidence.

Read PDF

Similar papers

Open access Aug 2026

Impact of balloon guide catheter use on procedural efficacy and early neurological outcomes in endovascular thrombectomy for anterior circulation acute ischemic stroke: a propensity-score-matched analysis.

BGC use favorably affected reperfusion efficacy, and its association with ENI appeared largely mediated through procedural factors.

Natalie van Landeghem, Katharina Kölker, Jordi Kühne Escolà et al. · 0 citations
Open access Aug 2026

Temporary flow arrest using EMBOGUARD™ balloon guide catheter may improve functional outcomes in acute stroke thrombectomy: a multicenter retrospective study

Background Balloon guide catheters (BGCs) have demonstrated benefits in mechanical thrombectomy (MT) for acute ischemic stroke (AIS), including improved recanalization rates and reduced distal embolization. The EMBOGUARD™ balloon guide catheter (Johnson & Johnson Neurovascular, Irvine, CA) represents a novel design wit...

R. Morsi, S. Falk, Elena Badillo Goicoechea et al. · 0 citations
Review Open access Sep 2026

Endovascular Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion with Large Ischemic Core: A Systematic Review and Meta-Analysis

It is suggested that EVT is associated with improved functional outcomes compared with MM alone, particularly in evidence derived from RCTs, while maintaining an acceptable safety profile.

Abdullah M. Alkutbi, H. Almohammed, Ahmed Salah Morad et al. · 0 citations
Open access Sep 2026

Outcomes Following First-Pass Direct Aspiration Versus Stent Retriever for Endovascular Thrombectomy in Primary Medium or Distal Vessel Occlusion: An Analysis of the SVIN Registry

Endovascular thrombectomy is increasingly performed for acute ischemic stroke due to medium vessel occlusion (MeVO); however, recent randomized trials—primarily using stent retriever (SR) techniques—have not demonstrated a clear benefit over medical management. This study aimed to compare the direct aspiration firs...

Stavros Matsoukas, A. Mehta, J. Fifi et al. · 0 citations
Review Open access Sep 2026

Evidence, strategies, and pathways for thrombectomy in medium vessel occlusion stroke: a systematic review

Background Medium vessel occlusions (MeVOs) account for 25–40% of acute ischemic strokes and present a significant therapeutic frontier. Despite high technical success rates of endovascular thrombectomy (EVT), recent randomized trial results have been nuanced, creating a paradox and underscoring the need for a precisio...

Chen-Ye Yang, Chen-Yang Zhao, Ya-Xuan Sun · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.